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Summary
Aims.— Myocardial infarction with unobstructed coronary artery disease represents a serious
diagnostic challenge. The role of cardiac magnetic resonance in the management of cardiomy-Acute coronary
syndrome;
Myocarditis;
Myocardial
infarction;
Takotsubo syndrome
opathies is increasing. We examined the diagnostic contributions of cardiac magnetic resonance
in patients presenting with acute chest pain syndrome, elevated serum cardiac troponin con-
centrations and no signiﬁcant coronary artery stenoses.
Methods.— Over a 3-year period, 107 consecutive patients (mean age 43.5 years; 62% men) pre-
sented to our institution with acute onset of chest pain, elevated serum troponin concentration
and unobstructed coronary arteries, and underwent 3-tesla cardiac magnetic resonance at a
Abbreviations: CMR, Cardiac magnetic resonance; cTn, Troponin concentration; FOV, Field of view; LVEF, Left ventricular ejection fraction;
TTE, Transthoracic echocardiography.
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mean delay of 6.9 days. A diagnosis was made based on: wall motion abnormalities and peri-
cardial effusion on cine mode; myocardial oedema on T2-weighted imaging; abnormalities on
ﬁrst-pass perfusion imaging; and late gadolinium enhancement on T1-weighted imaging.
Results.— Cardiac magnetic resonance was normal in 10.3% of patients and contributed a diag-
nosis in 89.7%, including myocarditis in 59.9%, stress cardiomyopathy (takotsubo syndrome) in
14% and myocardial infarction in 15.8%. Patients with normal cardiac magnetic resonance had a
signiﬁcantly lower mean peak troponin concentration (2.6 ng/mL) than patients with diagnostic
cardiac magnetic resonance (9.7 ng/mL; P = 0.01).
Conclusion.— Cardiac magnetic resonance contributed a diagnosis in nearly 90% of patients
presenting with acute chest pain, elevated serum troponin and unobstructed coronary arteries.
© 2011 Elsevier Masson SAS. All rights reserved.
MOTS CLÉS
IRM cardiaque ;
Syndrome coronaire
aigu ;
Myocardite ;
Infarctus du
myocarde ;
Syndrome de
takotsubo
Résumé
Objectif.— Les infarctus du myocarde sans lésion coronaire signiﬁcative constituent une dif-
ﬁculté diagnostique importante. Le rôle de l’IRM cardiaque dans la prise en charge des
cardiopathies est croissante. Nous avons étudié l’apport diagnostique de l’IRM cardiaque chez
les patients présentant un syndrome douloureux thoracique avec élévations des troponines et
absence de lésion coronaire signiﬁcative.
Méthode et résultats.— Sur une période de trois ans, 107 patients consécutifs (âge moyen :
43,5 ; hommes : 62 %) ont été hospitalisés dans notre service pour syndrome douloureux tho-
racique, troponine sérique élevée, absence de lésion coronaire signiﬁcative et ont bénéﬁcié
d’une IRM cardiaque 3 tesla dans un délai moyen de 6,9 jours. Le diagnostic était basé sur :
(a) la présence d’anomalies de la cinétique segmentaire ou d’un épanchement péricardique
sur les séquences « ciné » ; (b) d’un œdème myocardique sur les séquences pondérées T2 ; (c)
les anomalies de la perfusion de premier passage ; (d) le rehaussement tardif sur les séquences
pondérées T1. L’IRM était normal chez 10,3 % et a apporté un diagnostic chez 89,7 % des patients,
dont 59,9 % de myocardite, 14 % de cardiopathie de stress (syndrome de takotsubo) et 15,8 %
d’infarctus du myocarde. Les patients avec une IRM normale avaient un pic de troponine sig-
niﬁcativement plus bas (2,6 ng/ml) que les patients avec une IRM contributive (9,7 ng/ml ;
p = 0,01).
Conclusion.— L’IRM cardiaque apporte un diagnostic étiologique chez près de 90% des patients
présentant un syndrome douloureux thoracique avec élévations des troponines et absence de
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ntroduction
ardiac magnetic resonance (CMR) is a safe, non-invasive
nd reliable diagnostic test [1]. Chest pain syndrome with
levated troponin concentration (cTn) occurring in the
bsence of signiﬁcant coronary artery stenosis represents
serious diagnostic challenge [2,3]. Studies have recently
een published describing the usefulness of CMR in the diag-
osis of myocardial infarction [4—7], myocarditis [8—13] and
pical ballooning or ‘‘takotsubo syndrome’’ [14—17]. Con-
equently, its role is increasing in the initial diagnosis and
anagement of various heart diseases [18]. In this study, we
ought to deﬁne the prevalence of the different aetiologi-
al diagnoses in patients presenting with acute chest pain
yndrome, elevated serum cTn and unobstructed coronary
rteries, because few studies have been published regarding
he systematic use of CMR in this situation.ethods
his single-centre, prospective study enrolled consecutive
atients between November 2006 and November 2009 who
s
a
i
ws droits réservés.
resented with: acute onset of chest pain; serum cTn
0.1 ng/mL in two separate assays; and unobstructed coro-
ary arteries (stenosis <50% of the diameter of the vessel)
n angiography, computed tomography or both. Initial man-
gement, including left ventriculography or transthoracic
chocardiography (TTE), was carried out according to the
sual local practice. Patients with a history of myocardial
nfarction, signiﬁcant valvular disease or hypertrophic car-
iomyopathy were excluded.
ardiac magnetic resonance study
ll CMR examinations were performed with a 3-tesla
chieva® clinical imager (Philips Medical Systems, Best, The
etherlands). A six-element, phased-array, cardiac synergy
oil was used for signal detection. Cardiac synchronization
as performed using a four-electrode vectorcardiogram.
MR imaging associated cine and morphological sequences
or each patient, as described below.The typical protocol (see details below) involved three
tages, after surveys (scout views) to determine cardiac
xis locations. First, cine-mode sequences were acquired
n the short-axis view (left ventricular function) and T2-
eighted black-blood spin echo was carried out in the three
CMR in ACS and unobstructed coronary arteries
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ypical planes before gadolinium-chelate injection. Second,
rst-pass perfusion images were acquired in the short-axis
iew during a ﬁrst infusion of gadolinium-chelate; immedi-
tely after a second gadolinium injection, cine sequences
n four chambers and left ventricular long-axis views were
cquired. Third, about 8 to 10minutes after the second
njection, inversion-time scouting was carried out and then
ate gadolinium enhancement sequences were done in the
hree cardiac planes.
ine mode
teady-state, free precession sequences (balanced fast ﬁeld
cho) were acquired in three cardiac conventional planes
ith these typical settings: 30 phases/R-R; breath-hold
cquisition/each slice; slice thickness, 7mm without or with
inimal (≤1mm) gap; shortest TR/TE, typically 3.7/1.9ms;
ip angle, 45◦; ﬁeld of view (FOV), 320—400mm; tempo-
al resolution, 30—50ms; in-plane resolution, 2× 1.6mm;
atrix, 200× 256. In the short-axis view, 10—12 slices were
cquired with complete coverage of the left ventricle
rom base to apex, before injection of gadolinium-chelate
Dotarem®; Guerbet, Roissy, France). Left ventricular long-
xis (three slices) and four-chamber (four to ﬁve slices)
iews were acquired after the injection of gadolinium-
helate. In some difﬁcult cases, these views enabled
omplementary study of myocardial enhancement.
2-weighted black-blood spin echo
ultislice, monophase, single-shot, turbo, spin-echo
equences with inversion recovery and fat suppression
T2 BB SPAIR-SSH—T2 Black Blood spectral presaturation
ttenuated inversion-recovery single shot) were acquired.
he following settings were used in three planes covering
he entire left ventricle: 10 slices in short-axis view, seven
lices in left ventricular long-axis view, eight slices in
our-chamber view; breath-hold acquisition in mid-diastole;
lice thickness/gap, 7/0.7mm; TR, 2×R-R intervals; TE,
5ms; inversion time, 100ms; FOV, 370; matrix, 216× 86;
ip angle, 90◦.
irst-pass perfusion imaging
single-shot, spoiled, gradient-echo sequence with satura-
ion prepulse (dynamics turbo ﬁeld gradient-echo) was used
ith these typical settings: ﬁve to six non-contiguous slices
n short-axis view placed to cover the left ventricular basal
o apical planes and recorded continuously for each cardiac
ycle; slice thickness/gap, 8/8mm; shortest TR/TE, typi-
ally 3.8/1/9ms; ﬂip angle, 20◦; matrix, 128× 77; in-plane
esolution, 3× 5mm; FOV, 390; total duration, 1minute
ith partial breath-hold during initial myocardial enhance-
ent. The acquisition was synchronized to the intravenous
njection of 0.1mmol/kg of gadolinium-chelate at a rate of
mL/second, followed by a ﬂush infusion at the same rate.
ate gadolinium enhancement imaging
wo-dimensional, multislice, T1-weighted, inversion-
ecovery, spoiled, turbo-ﬁeld, gradient-echo sequences
Spoiled inversion recuperation turbo ﬁeld echo 3D
SIRTFE 3D]) were acquired 10minutes after a second
njection of 0.1mmol/kg gadolinium-chelate in three
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Table 2 Baseline characteristics of 107 study patients.
Characteristics
Clinical
Age (years) 43.5± 19
Men 67 (62.6)
Recent infection/inﬂammation 46 (42.9)
Recent stress 13 (12.1)
Biological
Peak serum concentration of
Troponin (ng/mL) 9.0± 11
C-reactive protein (mg/L) 49.2± 77
Electrocardiographic
Repolarization abnormalities 76 (71.0)
ST-segment elevation 14 (13.1)
Others 62 (57.9)
Transthoracic echocardiogram
LVEF at admission (%) 48.2± 13
LVEF ≤40% 32 (29.9)
Pericardial effusion 15 (14.0)
LVEF: left ventricular ejection fraction.
Values are means± standard deviations or numbers (%) of
p
t
p
s
Table 3 Baseline cardiac magnetic resonance charac-
teristics of 107 study patients.
CMR characteristics
Cine mode
LVEF (%) 53.4± 9
LVEF ≤40% 11 (10.3)
LV end-diastolic volume index (mL/m2) 72.6± 5
Pericardial effusion 11 (10.3)
T2-weighted spin-echo sequences
Oedema 53 (49.5)
First-pass perfusion imaging
Microvascular obstruction 4 (4.6)
Presence of late gadolinium enhancement 78 (72.9)
CMR: cardiac magnetic resonance; LV: left ventricular; LVEF:
left ventricular ejection fraction.
Values are means± standard deviations or numbers (%) of
observations.
s
1
a
1
Fobservations.lanes, with breath-holding for each stack. The inversion
ime was chosen to null healthy myocardium, with a
revious inversion-time scouting scan sequence. These
ettings were typically used: stack of 14—18 contiguous
T
r
igure 1. Flow of patients from screening to ﬁnal selection for entry ilices in the short-axis view; mean duration of apnoea,
8—20 seconds; 10—12 slices in left ventricular long-axis
nd four-chamber views; mean duration of apnoea,
2 seconds. Typical variables were: slice thickness, 10mm;
R/TE, 4/1.25ms; ﬂip angle, 15◦; FOV, 350—400; in-plane
esolution, 1.5× 2.4mm; matrix, 224× 142.
nto the study. CMR: cardiac magnetic resonance.
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the cine sequence. B. Hypersignal on the lateral wall on the T2-w
nodular late gadolinium enhancement. D. Extensive late gadolinium
Cardiac magnetic resonance analysis
The CRM scans were analysed by an experienced cardiolo-
gist and an experienced radiologist. Left ventricular ejection
fraction (LVEF) and volumes were measured on short-axis
stack cine imaging, using the dedicated software of a sepa-
rate ViewForumTM workstation (Philips). LVEF and volumes,
and the presence of myocardial abnormalities and pericar-
dial effusion, were ascertained using standard techniques
on cine mode [19]. T2-weighted sequences were visually
reviewed for high-signal-intensity areas, consistent with
myocardial oedema. The presence of microvascular obstruc-
tion was visually ascertained on ﬁrst-pass perfusion images.
Finally, the late gadolinium enhancement images were also
visually reviewed for the presence, anatomical distribution
and extent of subendocardial, subepicardial, mid-wall, and
transmural contrast enhancement. A ﬁnal CMR diagnosis was
made according to the criteria listed in Table 1. CMR imaging
was repeated if the images were interpreted as equivocal by
the experienced observers.Statistical analysis
The clinical, biological, electrocardiographic, TTE and CMR
characteristics of patients with diagnostic versus normal
p
o
a
L
iobserved in this study. A. Circumferential pericardial effusion on
ted sequence, corresponding to oedema. C. Subepicardial lateral
ancement.
MR were compared. Quantitative data are expressed as
eans± standard deviations. Between-group comparisons
ere made using Wilcoxon’s test. Qualitative data are
xpressed as percentages and were compared using the Chi2
r Fisher’s test, as appropriate. All analyses were performed
sing SAS® statistical package version 9.1 (SAS Institute Inc.,
ary, NC, USA). A P value <0.05 was considered statistically
igniﬁcant.
esults
tudy population
he ﬂow of patients between screening and entry into the
tudy is shown in Fig. 1. Among 854 patients referred to
ur institution for acute chest pain with cTn elevation, 114
13.3%) presented with an unobstructed coronary angiogram
nd 107 (12.5%) ultimately underwent CMR during the period
f study enrolment. The baseline characteristics of the study
opulation are presented in Table 2. No patient had a history
f cardiomyopathy before enrolment. Coronary computed
ngiotomography was performed in eight patients (7.4%).
VEF at admission was 48.2± 13%. An LVEF ≤40% was found
n 32 patients (29.9%) during the initial hospitalization and
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Figure 3. Cardiac magnetic resonance pattern of stress cardiomyopathy. A and B. Typical apical wall motion abnormalities in the cine
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lequences (Panel A, end-diastolic cine sequence; Panel B, end-syst
pical oedema. D. Absence of late gadolinium enhancement, conﬁr
lso reveals the presence of apical thrombus.
wo patients (1.8%) required extracorporeal life support for
and 22 days, before undergoing CMR.
ardiac magnetic resonance analysis
MR imaging was completed in all patients without adverse
vents (Figs. 2—4). The median delay between the onset
f symptoms and CMR was 5 days (mean 6.9± 9). A second
mage was obtained in nine patients (8.4%) because of equiv-
cal initial images. The baseline CMR characteristics of the
07 study patients are presented in Table 3. A CMR diag-
osis was made in 96 patients (89.7%), including myocarditis
n = 64, 59.9%), stress cardiomyopathy (takotsubo syndrome)
n = 15, 14.0%) and myocardial infarction (n = 17, 15.8%).
MR was normal in 11 patients (10.3%). No hypertrophic car-
iomyopathy was found in this setting. The main clinical,
iological, electrocardiographic, TTE and CMR observations
ade in the various ﬁnal diagnostic subgroups are summa-ized in Table 4 and patients with diagnostic versus normal
MR are compared in Table 5.
The median age of the 64 patients with a ﬁnal CMR diag-
osis of myocarditis was 37 years, 71.8% were men and
2.5% had a recent history of viral infection or non-speciﬁc
l
1
t
o
dine sequence). C. T2-weighted sequence showing the presence of
the diagnosis of takotsubo syndrome. Cardiac magnetic resonance
nﬂammation. Two patients (1.8%) had been previously hos-
italized for management of myocarditis. Four of these
4 patients (3.7%) had inﬂammatory diseases, including
cleroderma, Wegener’s granulomatosis [20], rheumatoid
rthritis and Crohn’s disease. Fifteen patients (14.0%) pre-
ented with heart failure during the initial hospitalization;
wo of these patients needed circulatory mechanical assis-
ance. The median delay between the onset of chest pain
nd the CMR scan was 4 days.
The median age of the 15 patients presenting with stress
ardiomyopathy (or takotsubo syndrome) was 64 years,
6.6% were post-menopausal women and 86.6% had recent
tress distinctly identiﬁed, including mourning (n = 2), dis-
ase or medical examinations (n = 5), travel (n = 3), family
onﬂicts (n = 2) and a house ﬁre (n = 1). A history of acute
pical ballooning syndrome was elicited in three patients
20.0%), without CMR scan obtained 3, 5 and 10 years ear-
ier. Despite only mild elevation of the cardiac enzymes,
eft ventricular dysfunction was severe, with 80.0% of these
5 patients presenting with an LVEF ≤40% during hospitaliza-
ion. At the time of CMR scan, obtained after a median delay
f 4 days, mean LVEF was 49.5%. An apical thrombus was
etected by CMR in one patient (6.6%). Two patients (13.3%)
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Figure 4. Cardiac magnetic resonance pattern of myocardial infarction. A and B (initial scan). T2-weighted sequence (Panel A) showing
the presence of inferoseptal oedema with concordant but equivocal presence of late gadolinium enhancement (Panel B). C and D (follow-up
nce
aetio
i
c
m
h
D
T
t
c
n
D
r
I
p
1
t
iscan, 4months later). T2-weighted sequence showing the disappeara
enhancement in a thinned segment is consistent with an ischaemic
developed life-threatening ventricular tachyarrhythmias,
including ventricular ﬁbrillation in one patient and ventric-
ular tachycardia causing syncope in the other patient.
The 17 patients with a CMR diagnosis of myocardial
infarction, despite the absence of obstructed coronary
artery disease, represented a less homogeneous group,
whose median age was 44 years. These 10men and seven
women presented without clinically contributory factors,
such as recent inﬂammation, infection or stress. Despite
a median delay of 5 days between TTE and CMR, the two
tests yielded similar mean measurements of LVEF (51.3± 8%
and 49.6± 7%, respectively). Complications were observed
during the initial hospitalization in four patients (23.5%)
including apical thrombi in two patients (one of whom had a
reversible stroke) and sustained ventricular tachyarrhyth-
mias in two patients. Finally, this initial ischaemic event
disclosed the presence of sarcoidosis (n = 1), lupus erythe-
matosus (n = 1) and paroxysmal atrial ﬁbrillation (n = 1).
In the 11 patients with normal CMR, the median delay
between onset of chest pain and imaging was 6 days. No par-
ticular clinical characteristic was identiﬁed in this group of
patients. The main signiﬁcant differences between patients
with normal versus diagnostic CMR were a lower mean peak
cTn (2.6 vs 9.7 ng/mL, P = 0.01), a better left ventricu-
lar systolic function (lowest LVEF 59.7 vs 46.8%, P < 0.001)
and fewer patients with LVEF ≤40% (0 vs 33.3%, P = 0.019)
1
s
y
ﬁ
tof oedema (Panel C) but the presence of transmural late gadolinium
logy for the initial chest pain syndrome (Panel D).
n the ‘‘normal’’ CMR group. This group remained free of
omplications and, except for one patient with pheochro-
ocytoma, had no concomitant illness diagnosed during
ospitalization.
iscussion
his is the ﬁrst report on the systematic application of 3-
esla CMR in a population of patients presenting with acute
hest pain, elevated serum cTn and no angiographically sig-
iﬁcant coronary artery disease.
iagnostic contributions of cardiac magnetic
esonance
n this study, CMR provided a diagnosis in nearly 90% of
atients. In a previous study by Assomull et al., who used a
.5-tesla magnet in a similar but smaller patient population,
he overall diagnostic contribution of CMR was 65%, includ-
ng myocarditis in 50% of patients, myocardial infarction in
1.6% of patients and cardiomyopathy (including takotsubo
yndrome) in 3.4% of patients [21]. The higher diagnostic
ield of CMR in our study can be explained by: the higher
eld strength, higher signal-to-noise ratio and higher sensi-
ivity of 3-tesla compared with 1.5-tesla CMR (although few
168 G. Leurent et al.
Table 4 Main observations according to the ﬁnal cardiac magnetic resonance diagnosis.
Observations Myocarditis
(n = 64)
Takotsubo
syndrome
(n = 15)
Myocardial
infarction
(n = 17)
Normal CMR
(n = 11)
Clinical
Age (years) 36.8± 15 64.4± 17 44.5± 19 52.7± 16
Men 46 (71.8) 2 (13.3) 10 (58.8) 4 (36.3)
Recent infection/inﬂammation 40 (62.5) 0 3 (17.6) 3 (27.2)
Recent stress 0 13 (86.6) 0 0
Biological
Peak serum concentration of
Troponin (ng/mL) 10.5± 11 3.4± 3 12.4± 14 2.6± 3
C-reactive protein (mg/L) 59.9± 88 30.0± 36 12.4± 16 61.4± 76
Electrocardiographic
Repolarization abnormalities 39 (60.9) 15 (100) 15 (88.2) 7 (63.3)
Transthoracic echocardiography
LVEF at admission (%) 48.3± 13 35.8± 11 51.3± 8 59.7± 5
LVEF ≤40% 17 (26.5) 12 (80.0) 3 (17.6) 0
Pericardial effusion 13 (20.3) 0 2 (11.7) 0
Thrombus 0 0 1 (5.9) 0
Cardiac magnetic resonance
LVEF (%) 54.4± 9 49.5± 12 49.6± 7 59.9± 4
LVEF ≤40% 4 (6.2) 4 (26.6) 3 (17.6) 0
LV end-diastolic volume index (mL/m2) 70.6± 8 78.2± 16 74.1± 7 68.0± 6
Pericardial effusion 9 (14.0) 0 2 (11.7) 0
Thrombus 0 1 (6.6) 2 (11.7) 0
Oedema 37 (57.8) 6 (40.0) 10 (58.8) 0
Microvascular obstruction 0 0 4 (23.5) 0
Presence of late gadolinium enhancement 61 (95.3) 0 17 (100) 0
CMR: cardiac magnetic resonance; LV: left ventricular; LVEF: left ventricular ejection fraction.
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tudies have compared the performances of these two types
f magnets in the cardiovascular medicine setting [22]); and
he shorter delay between onset of chest pain and CMR imag-
ng. In the study by Assomull et al., the median interval
etween rise in serum cTn and CMR was 14.5 days compared
ith a median delay between onset of symptoms and CMR of
days in our study. During this interval of 9.5 days, several
ransient abnormalities that are detectable by CMR (such as
yskinetic wall motion, pericardial effusion and myocardial
edema), might have resolved. A more recent study from
pain, in 80 patients presenting with acute coronary syn-
rome and normal coronary arteries, reported results with
.5-tesla CMR imaging that were similar to ours [23]. In that
tudy, CMR provided a diagnosis in 95% of patients, includ-
ng myocarditis in 63% of patients, myocardial infarction in
5% of patients and takotsubo cardiomyopathy in 11% of
atients. Finally, in a population of only 23 patients, Chris-
iansen et al. observed a 30% prevalence of myocardial scar
24]. This low prevalence can be explained by the exclusion
rom the study of patients presenting with changes consis-
ent with myocarditis, limiting the population to patients
ith myocardial infarction in the absence of occlusive coro-
ary artery disease. A similar patient selection in our study
ould have yielded a 39.5% prevalence of myocardial scar.
g
s
t
s
m.
CMR for patients with elevated cTn, acute chest pain
yndrome and unobstructed coronary arteries has a great
mpact on patient management, as knowledge of the diag-
osis allows a better management of the disease. For
nstance, secondary prevention (statin, platelet aggregation
nhibitors) may be necessary in case of myocardial infarc-
ion.
isease prevalence
n our study, nearly 15% of patients presenting to our insti-
ution with acute chest pain and serum cTn >0.1 ng/mL had
ngiographically unobstructed coronary arteries. This pro-
ortion is concordant with those previously reported. In the
RISC II (Fragmin and fast revascularisation during instability
n coronary artery disease II) study, 14% of the 2457 patients
resenting with acute chest pain and elevated serum cTn
r electrocardiographic changes had unobstructed coronary
rteries [25]. Similar observations were made in the Platelet
lycoprotein IIb/IIIa in unstable angina: receptor suppres-
ion using integrilin therapy (PURSUIT) study, with 12% of
he 5767 patients presenting with unstable angina free from
igniﬁcant lesion on coronary angiograms [26]. Finally, in a
eta-analysis of three separate Thrombolysis in myocardial
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Table 5 Main observations made in patients with diagnostic versus normal cardiac magnetic resonance.
Observations CMR p
Diagnostic (n = 96) Normal (n = 11)
Clinical
Age (years) 42.4± 19 52.7± 16 0.059
Men 63 (65.6) 4 (36.3) 0.057
Recent infection/inﬂammation 43 (44.7) 3 (27.2) 0.26
Recent stress 13 (13.5) 0 0.19
Biological
Peak serum concentration of
Troponin (ng/mL) 9.7± 11 2.6± 3 0.01
C-reactive protein (mg/L) 48.2± 78 61.4± 67 0.43
Electrocardiographic
Repolarization abnormalities 69 (71.8) 7 (63.3) 0.56
Transthoracic echocardiography
LVEF at admission (%) 46.8± 12 59.7± 5 <0.01
LVEF ≤40% 32 (33.3) 0 0.019
Pericardial effusion 15 (15.6) 0 0.15
Cardiac magnetic resonance
LVEF (%) 52.6± 9 59.9± 4 0.008
LVEF ≤40% 11 (11.4) 0 0.23
LV end-diastolic volume index (mL/m2) 72.4± 12 68.0± 6 0.1
Pericardial effusion 11 (11.4) 0 0.23
Oedema 53 (55.2) 0 <0.001
Microvascular obstruction 4 (4.1) 0 0.49
Presence of late gadolinium enhancement 78 (81.2) 0 <0.001
CMR: cardiac magnetic resonance; LV: left ventricular; LVEF: left ventricular ejection fraction.
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pValues are means± standard deviations or numbers (%) of observa
infarction (TIMI) trials, 710 of 7656 patients (9.1%) had no
angiographically visible coronary artery stenosis [27].
Normal cardiac magnetic resonance
Approximately 10% of patients presenting with acute chest
pain syndrome and elevated serum cTn had normal CMR
imaging studies. This may be partially explained by a
longer median delay of 6 days between the onset of chest
pain and CMR in this subgroup of patients versus 5 days
in patients with contributory studies. We do not believe
that the hypothesis of a false-positive elevation of cTn is
plausible, as: repolarization abnormalities were present on
the electrocardiogram in >60% of patients who had normal
CMR images; in this group, the mean peak serum cTn was
2.6 ng/mL, far higher than 0.01 ng/mL (the upper limit of
normal concentrations); and the mean peak serum concen-
tration of C-reactive protein was 61mg/L, also markedly
above the upper limit of normal concentrations of 5mg/L.
These abnormalities were the manifestations of an unidenti-
ﬁed underlying disorder. A modest yet unequivocal increase
in cTn above the normal range is a sign of minimal myocar-
dial necrosis. As the size of late gadolinium enhancement
reﬂects the amount of necrosis [28,29], the size of the
necrosis may have been insufﬁcient to be detectable by
CMR. Finally, it is noteworthy that all TTEs in this group
y
w
s
w
n.
ere normal, suggesting that diagnostic tests that explore
he cardiac structures are not helpful in these patients.
tudy limitations
n this study, the ﬁnal diagnosis was not systemati-
ally conﬁrmed by histological analyses, in compliance
ith our institutional guidelines for the management of
hese patients, which do not include endomyocardial biop-
ies. Second, few patients underwent computed coronary
ngiotomography instead of coronary angiography. This is
xplained by the initial clinical presentation, often suggest-
ng the presence of a myocardial infarction with ST-segment
levation, the management of which, in our institution,
ncludes the direct admission of the patient to the catheter-
zation laboratory. Third, we did not examine the early
yocardial gadolinium enhancement, which might have
ighlighted myocardial hyperaemia in myocarditis [9] and
educed the number of normal CMR images. Fourth, the
atients were not followed long term, which might have
ielded prognostic information, particularly in the group
ith normal CMR images. Finally, despite being the largest
tudy published thus far, the sample size in this single centre
as small. Therefore, we believe that a multicentre registry
eeds to be organized.
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onclusions
MR now plays a key role in the initial diagnosis and manage-
ent of patients presenting with elevated serum cTn, acute
nset of chest pain and unobstructed coronary arteries. CMR
afely allowed the non-invasive identiﬁcation of an aetiol-
gy without irradiation in approximately 90% of patients.
he role of CMR needs to be emphasized, and a multicentre
egistry organized with a view to gathering further data on
his common clinical presentation.
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